|
Report (reference)
|
n
|
Median age (years)
|
Stage (%)
|
Median Time from surgery to RT (weeks)
|
Systemic therapy (%)
|
Median follow-up (mts)
|
LRFS (%)
|
LRRFS (%)
|
OS (%)
|
|---|
|
Studer (7)
|
28
|
61*
|
III (14)
|
nr
|
86
|
19
|
92#
|
nr
|
83#
|
|
IV (54)
|
|
Chen (10)
|
22
|
50
|
III (27)
|
nr
|
9
|
44
|
nr
|
64**
|
67¶
|
|
IV (73)
|
|
Gomez (9)
|
35
|
nr
|
III (26)
|
7
|
29
|
28
|
89**
|
77
|
74
|
|
IV (54)
|
|
Daly (11)
|
30
|
61
|
III (23)
|
6
|
60
|
38
|
67
|
53
|
60
|
|
IV (53)
|
|
Sher (13)
|
30
|
nr
|
nr
|
7
|
nr
|
nr
|
nr
|
91#
|
85#
|
|
Present analysis
|
53
|
60
|
III (13)
|
7
|
55
|
28
|
83
|
79
|
73
|
| | | |
IV (57)
| | | | | | |
- Abbreviations: LRFS local recurrence-free survival, LRRFS locoregional recurrence-free survival, mts months, n eligible patients, nr not reported separately, OS overall survival, RT radiotherapy,*mean age; #2 year actuarial estimates; three year actuarial estimates; **Crude rate.
